#United States #Washington #Research Awards #Lung Cancer #LUNGevity

LUNGevity Foundation's New Research Awards for Lung Cancer

The LUNGevity Foundation, a pivotal player in lung cancer advocacy and research, has recently announced the opening of four Requests for Applications (RFAs) aimed at bolstering the lung cancer research workforce. This initiative, launched on January 13, 2025, underscores the organization's commitment to improving outcomes for patients affected by this devastating disease.

The Importance of a Robust Research Community

In a statement, Dr. Upal Basu Roy, the executive director of LUNGevity Research, emphasized the significance of a vibrant research community in facilitating advancements in early detection and treatment of lung cancer. He stated, “For more than a decade, LUNGevity has supported researchers through award mechanisms that address the specific needs of the lung cancer community. Each award we offer is strategically designed to create a skilled research and clinical trial workforce focused on supporting individuals living with lung cancer.”

Overview of the Research Awards

Among the awards being offered in 2025, the following programs stand out:

1. Career Development Awards (CDAs)

Celebrating their 13th year, the Career Development Awards (CDAs) serve as LUNGevity's flagship program. They have gained a reputation for providing essential funding and networking opportunities that propel early-career researchers into prominent positions within the field.
Dr. Amy Moore, Vice President of Global Engagement and Research Partnerships, noted, “Despite lung cancer being the foremost cancer-related cause of death, federal funding for its research remains minimal, accounting for only 6% of cancer-related research dollars.”
The CDAs offer a maximum award of $300,000 over three years, providing vital resources to junior investigators eager to establish a focus on lung cancer.

2. Health Equity and Inclusiveness Research Fellow Awards

Introduced in 2021, these awards reflect LUNGevity's commitment to nurturing a diverse lung cancer workforce. Addressing the unique needs of underserved populations has proven crucial in enhancing patient care and outcomes. This award allocates up to $100,000 over a two-year period for groundbreaking initiatives focused on inclusivity.

3. Veterans Affairs Research Scholar Awards

Acknowledging the heightened risk of lung cancer among veterans, these awards support translational research efforts for fellows and junior faculty within the US Department of Veterans Affairs. With a financial backing of up to $100,000 over two years, this program aims to promote research addressing lung cancer's impact on veterans.

4. ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grants

In collaboration with the American Society for Radiation Oncology, LUNGevity has launched seed grants specifically designed for residents and fellows interested in radiation oncology research pertinent to lung cancer. This grant provides a maximum of $50,000 for one year to support innovative research projects.

Application Timeline and Process

The deadline for submitting applications for the ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grants is set for March 10, 2025. Meanwhile, all other LUNGevity awards will employ a two-step application process, with a letter of intent due by February 14, 2025.
Those seeking additional information about these awards can visit the LUNGevity website or the proposalCENTRAL platform. Announcements regarding the award recipients are expected to occur in late summer 2025.

Making a Lasting Impact

The LUNGevity Foundation is unwavering in its mission to transform the landscape of lung cancer treatment and research. Striving to enhance the quality of life and survivorship for those affected by lung cancer, LUNGevity is committed not only to advancing research but also to promoting health equity across the healthcare continuum.
Through innovative research strategies, advocacy, and community support, LUNGevity aims to create a future where lung cancer is detected earlier, treated more effectively, and ultimately, where no one succumbs to this disease. To find out more, visit LUNGevity’s official website.